Menopause series
Mounjaro and HRT: Taking Them Together
Thousands of UK women now use Mounjaro and HRT at the same time, often prescribed by two services that have never spoken to each other. The combination is common and there is no rule against it, but Mounjaro slows stomach emptying, and that raises a genuine question over the tablet forms of HRT. This guide sets out which types are affected, what the British Menopause Society advises, what the newest research says about results, and exactly who needs to know what.
Key facts
- HRT delivered through the skin, meaning patches, gels and sprays, does not pass through the stomach, so Mounjaro’s slowed stomach emptying does not affect it. The British Menopause Society already prefers transdermal oestrogen for women with overweight or obesity.
- Oral progestogen, such as Utrogestan capsules, is the main question mark. If less is absorbed, the womb lining may be less protected, so the BMS advises discussing non-oral progestogen options with your prescriber.
- Any unscheduled bleeding on HRT while using Mounjaro should always be checked by a clinician, never waited out.
- Perimenopausal women can still conceive. With oral contraception, UK guidance is to add a barrier method or switch to a non-oral method for four weeks after starting Mounjaro and after each dose increase. Mounjaro must not be used in pregnancy.
- A January 2026 study in The Lancet Obstetrics, Gynaecology and Women’s Health found postmenopausal women on hormone therapy lost around 35% more weight on tirzepatide, though it was retrospective and needs confirming.
Can you take Mounjaro and HRT together?
Yes, and many women do. There is no listed contraindication between tirzepatide and HRT, and no requirement to stop one before starting the other. The practical risk is not the medicines themselves but the information gap around them: a large share of UK Mounjaro users buy privately from an online pharmacy while their HRT comes from their GP or an NHS menopause clinic, and neither prescriber automatically knows about the other.
Closing that gap is the single most useful thing you can do. Declare your full HRT regimen, brand names and routes included, on every Mounjaro consultation form, and tell whoever manages your HRT that you are using Mounjaro, including when your dose goes up. Every judgement on this page is one your prescribers can only make if they have the full picture.
Why stomach emptying matters
Mounjaro slows how quickly the stomach empties. That is partly how it works, because meals satisfy for longer, but anything swallowed sits in the stomach longer too, which can change how much of an oral medicine reaches the bloodstream and how quickly. The effect is strongest after the first dose and after each dose increase, then eases as the body adjusts over the following weeks.
There is no direct study of HRT tablets and tirzepatide yet. The signal comes from contraception research: tirzepatide reduced peak blood levels of the combined oral contraceptive pill substantially, which is why UK guidance added the four-week barrier rule for pill users. Menopause specialists apply the same logic to oral HRT as a precaution, and that is the basis of the British Menopause Society’s advice below.
What it means for each type of HRT
The route into your body is what decides whether Mounjaro is relevant. Anything through the skin or acting locally bypasses the stomach entirely.
| HRT type | Affected by Mounjaro? | What to know |
|---|---|---|
| Oestrogen or combined patches (Evorel, Estradot, FemSeven) | No | Absorbed through the skin, so stomach emptying is irrelevant. No change needed. |
| Gels and sprays (Oestrogel, Sandrena, Lenzetto) | No | Also skin routes. The BMS prefers transdermal oestrogen for women with overweight or obesity in any case. |
| Oestrogen tablets (Elleste Solo, Progynova) | Possibly | Absorption may become less predictable, particularly around dose increases. Worth asking your prescriber whether a patch, gel or spray suits you better. |
| Oral progestogen (Utrogestan, norethisterone tablets) | The main concern | Progestogen protects the womb lining when you take oestrogen. Reduced absorption could weaken that protection, so the BMS advises discussing non-oral options such as the hormonal coil or the vaginal route. |
| Vaginal or local oestrogen (Vagifem, Gina, creams) | No | Acts locally with minimal absorption into the body. Unaffected. |
| Testosterone gel | No | A skin route, so unaffected by stomach emptying. |
Do not change or stop anything on the strength of this table alone. It exists so you know which questions to ask; the answers belong to your prescriber, who knows your history.
Bleeding and other warning signs
Unscheduled bleeding affects a significant share of HRT users at some point, so bleeding alone does not mean something is wrong. But if you take oestrogen with an oral progestogen and you are on Mounjaro, bleeding is also the most likely first sign that the progestogen is not being absorbed well enough to protect the womb lining. The rule is simple: any new, changed or persistent bleeding on HRT gets reviewed by a clinician, whatever you suspect the cause to be.
Two other situations deserve a mention. A day of repeated vomiting or severe diarrhoea, which some people get after a Mounjaro dose increase, can reduce the absorption of any tablet taken that day, HRT included. And if long-standing menopause symptoms return out of nowhere, that can be a sign your oral HRT is delivering less than it was, which is worth reporting rather than enduring.
Does HRT change your results on Mounjaro?
Possibly, and in an encouraging direction. A Mayo Clinic team first noticed the pattern with semaglutide: postmenopausal women using hormone therapy lost about 16% of their body weight over 12 months against 12% without it. In January 2026 the same group published a matching analysis for tirzepatide in The Lancet Obstetrics, Gynaecology and Women’s Health, covering 120 postmenopausal women treated for a year or more, and found those on hormone therapy lost around 35% more weight.
Both studies were retrospective, meaning researchers looked back at records rather than running a controlled trial, so they show an association rather than proof. The mechanism is plausible, because hormone therapy is known to soften the visceral fat gain and muscle loss of menopause, but the honest reading is that this is promising early evidence. It is not a reason to start HRT. HRT is a decision about menopause symptoms, weighed against your personal risks with your own clinician, and NICE guidance frames it exactly that way. If you already take it, this research simply suggests the combination may serve you well.
Perimenopause, contraception and pregnancy
HRT is not contraception, and perimenopausal women can still conceive. UK advice is that contraception is needed until 12 months after your last natural period if you are over 50, and for 24 months if you are under 50. That matters here because Mounjaro must not be used in pregnancy.
If you use an oral contraceptive alongside Mounjaro, the guidance is specific: add a barrier method such as condoms, or switch to a non-oral method, for four weeks after starting and for four weeks after each dose increase, because absorption of the pill may be reduced in those windows. If you are planning a pregnancy, Mounjaro should be stopped at least one month before you start trying. Your prescriber or a sexual health service can help you choose a method that is not affected at all.
Who decides, and what to tell them
Nothing on this page is a decision you should make alone, and equally nothing here requires a crisis appointment. It is a short conversation with each prescriber. Tell your Mounjaro provider your exact HRT regimen, including brand names and whether each part is a tablet, patch, gel, spray or coil. Tell your GP or menopause clinic that you use Mounjaro, what dose you are on, and when it changes. Ask the Utrogestan question directly if it applies to you. And if you change pharmacy for your Mounjaro, carry the same information across.
One more thing worth raising at reviews: as you lose weight, your HRT needs can shift, because body fat itself produces and stores oestrogen. Doses that suited you at your starting weight may deserve a fresh look after significant loss. That is a routine adjustment, not a problem, and another reason the people prescribing for you should know the whole picture. For the background on why weight changes at menopause in the first place, see our guide to menopause weight gain and Mounjaro, and for what each route costs, our menopause weight loss cost guide.
Common questions
Can I take Mounjaro and HRT at the same time?
Yes. The combination is common and there is no listed contraindication. The important part is that both prescribers know: your Mounjaro provider should have your full HRT regimen, and whoever manages your HRT should know you use Mounjaro.
Does Mounjaro stop HRT working?
Patches, gels, sprays and vaginal oestrogen are unaffected because they bypass the stomach. Tablet forms may be absorbed less predictably, particularly in the weeks after starting or increasing your dose, which is why oral HRT deserves a conversation with your prescriber.
What about Utrogestan?
Oral progesterone is the main thing specialists want reviewed, because it protects the womb lining and reduced absorption could weaken that protection. The British Menopause Society advises discussing non-oral options such as the hormonal coil or vaginal route. Do not stop it yourself.
Do I need to change my HRT patches when starting Mounjaro?
No. Patches deliver hormones through the skin, so slowed stomach emptying makes no difference to them. The same applies to gels and sprays.
Does HRT make Mounjaro work better?
Early research points that way: a 2026 study found postmenopausal women on hormone therapy lost around 35% more weight on tirzepatide. It was retrospective, so it is promising rather than proven, and it is not a reason to start HRT for weight loss alone.
Can Mounjaro affect my contraception during perimenopause?
If you take an oral contraceptive, yes. Use a barrier method as well, or switch to a non-oral method, for four weeks after starting Mounjaro and after each dose increase. Coils, implants, injections and patches are unaffected.
I have had bleeding on HRT since starting Mounjaro. What should I do?
Get it checked. Unscheduled bleeding on HRT always warrants a clinical review, and on Mounjaro it can be the first sign that an oral progestogen is not being absorbed well enough. It is usually straightforward to resolve, often by changing the route.
Sources
- British Menopause Society. Tool for Clinicians: Use of incretin-based therapies. April 2025.
- Medicines and Healthcare products Regulatory Agency, via the electronic medicines compendium. Mounjaro: Summary of Product Characteristics, sections 4.5 and 4.6.
- Castaneda R et al. The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women. The Lancet Obstetrics, Gynaecology and Women’s Health, 2026.
- Hurtado MD et al. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause, 2024.
- National Institute for Health and Care Excellence. Menopause: identification and management (NG23).
Monj is an independent price information service operated by Medstack Ltd. It does not sell, prescribe or supply medicines and does not give medical advice. Never start, stop or switch HRT, contraception or Mounjaro without speaking to your prescriber. Report suspected side effects through the MHRA Yellow Card scheme.
